EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, FGEN: Fibrogen Inc CS

24 Dec 25 13:00
LAST:

8.585

CHANGE:
 0.16		OPEN:
8.420		HIGH:
8.585		ASK:
52.500		VOLUME:
4.0K
CHG(%):
1.84		PREV:
8.430		LOW:
8.380		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Dec 258.4208.5858.3808.5857.2K
23 Dec 258.5208.7908.4208.43026.1K
22 Dec 258.5008.8008.5008.56023.5K
19 Dec 258.3508.9208.3508.60032.6K
18 Dec 258.8509.0408.3008.32041.6K
17 Dec 259.4809.5158.6608.66051.2K
16 Dec 259.82010.4709.3009.51047.9K
15 Dec 258.66010.4508.60010.040339.0K
12 Dec 258.7108.7958.3708.38011.8K
11 Dec 258.7709.0888.7008.70012.1K

PROFILE

Name:Fibrogen Inc CS
About:FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. Its pipeline products include FG-3165 and FG-3175, an anti-GAL-9 antibody for treatment of solid tumors. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:350 Bay Street, San Francisco, CA, United States, 94133
Website:https://www.fibrogen.com
CUSIP:31572Q808
CIK:0000921299
ISIN:US31572Q8087
FIGI:BBG000FW5ZL6
LEI:549300Q914ULWWY95822

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.92 
Forward P/E:-16.12 
PEG Ratio:0.00 
Price to Sales:6.12 
Price to Book:-0.25 
Profit Margin:-0.28 
Operating Margin:-8.65 
Return on Assets:-0.16 
Return on Equity:0.26 
EPS Ratio:-21.61 
Revenue:7.35M 
Shares:4.04M 
Market Cap:34.72M 

TECHNICAL INDICATORS

MA5:8.501.0%
MA10:8.782.3%
MA20:8.630.5%
MA50:9.5511.2%
MA100:10.2619.5%
MA200:6.3335.6%
STO9:12.33 
STO14:12.33 
RSI14:53.27
WPR14:-84.59 
MTM14:0.17
ROC14:0.02 
ATR:0.60 
Week High:9.5110.8%
Week Low:8.303.4%
Month High:10.4722.0%
Month Low:7.9935.6%
Year High:12.6046.8%
Year Low:0.233,632.6%

RECENT SPLITS

Date Ratio
17 Jun 20251-25